You may also like
Testing an Old Therapy Against a New Disease: Convalescent Plasma for COVID-19
For now—and possibly the next 18 to 24 months, convalescent plasma, despite supply issues and questions about efficacy and who is most likely to benefit from treatment, remains the only off-the-shelf therapy for COVID-19.
1 min read
The Association Between Intraoperative Cell Salvage and Red Blood Cell Transfusion in Cardiac Surgery – An Observational Study in A Patient Blood Management Centre
Here, we evaluate the benefit of CS in a large number of patients undergoing elective cardiac surgery at a designated PBM centre. We hypothesised that the use of CS is associated with a decreased proportion of patients exposed to RBC transfusion as an individual measure in a comprehensive PBM program.
1 min read
Much Ado About Something: The Pros and Cons of Licensure (Video)
Carl Dinger discusses the pros and cons of licensure for perfusionists (47 minutes).
1 min read